The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Celgene; Janssen; Merck; Onyx
Effect of carfilzomib, lenalidomide, and dexamethasone (KRd) vs lenalidomide and dexamethasone (Rd) in patients with relapsed multiple myeloma (RMM) by line of therapy: Secondary analysis from an interim analysis of the phase III study ASPIRE (NCT01080391).
 
Meletios A. Dimopoulos
Honoraria - Celgene; Onyx
Consulting or Advisory Role - Celgene; Onyx
 
A. Keith Stewart
No Relationships to Disclose
 
S. Vincent Rajkumar
No Relationships to Disclose
 
Tamás Masszi
No Relationships to Disclose
 
Albert Oriol
Consulting or Advisory Role - Celgene; Janssen
Speakers' Bureau - Celgene; Janssen
 
Roman Hajek
No Relationships to Disclose
 
Laura Rosinol
Honoraria - Celgene; Janssen
 
David Samuel DiCapua Siegel
Honoraria - Celgene; Millennium; Onyx
Speakers' Bureau - Celgene; Millennium; Onyx
 
Georgi Mihaylov
No Relationships to Disclose
 
Vesselina Goranova-Marinova
No Relationships to Disclose
 
Peter Rajnics
No Relationships to Disclose
 
Aleksandr Suvorov
No Relationships to Disclose
 
Ruben Niesvizky
Consulting or Advisory Role - Celgene; Millennium; Onyx
Speakers' Bureau - Celgene; Millennium; Onyx
 
Andrzej J. Jakubowiak
Honoraria - Onyx
Consulting or Advisory Role - Onyx
Speakers' Bureau - Onyx
Research Funding - Onyx
 
Jesus F. San Miguel
Other Relationship - Celgene; Onyx
 
Heinz Ludwig
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Onyx
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Onyx
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Onyx
Research Funding - Takeda (Inst)
 
Naseem J. Zojwalla
Employment - Onyx
Stock and Other Ownership Interests - Onyx
Travel, Accommodations, Expenses - Onyx
 
Philippe Moreau
Honoraria - Celgene; Janssen; Millennium; Novartis; Onyx
Consulting or Advisory Role - Celgene; Janssen; Millennium; Novartis; Onyx
 
Antonio Palumbo
Honoraria - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene; Genmab; Janssen-Cilag; Millennium; Onyx; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Genmab; Janssen-Cilag; Millennium; Onyx